Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Hydrocortisone vs Diclofenac for TMJ Arthralgia
NCT05816226Phase 3Recruiting
- Sponsor
- University of the Pacific
- Start
- Jun 2023
- Primary completion
- Jan 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Alkindi Sprinkle in temporomandibular joint arthralgia (2 arms), sponsored by University of the Pacific. Primary endpoints: Change in pain intensity at Day 21 and Change in jaw function limitation at Day 21. Started Jun 2023; status: recruiting.
02
Drugs
Alkindi Sprinkle
03
Conditions
temporomandibular joint arthralgia
Beyond the preview
Go deeper on NCT05816226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05816226.